Michelle W. Wong‐Brown

1.8k total citations · 1 hit paper
28 papers, 1.2k citations indexed

About

Michelle W. Wong‐Brown is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Michelle W. Wong‐Brown has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Genetics and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Michelle W. Wong‐Brown's work include DNA Repair Mechanisms (9 papers), BRCA gene mutations in cancer (9 papers) and Epigenetics and DNA Methylation (7 papers). Michelle W. Wong‐Brown is often cited by papers focused on DNA Repair Mechanisms (9 papers), BRCA gene mutations in cancer (9 papers) and Epigenetics and DNA Methylation (7 papers). Michelle W. Wong‐Brown collaborates with scholars based in Australia, United States and China. Michelle W. Wong‐Brown's co-authors include Nikola A. Bowden, Rodney J. Scott, Kelly A. Avery‐Kiejda, Andrea Mathe, Brianna C. Morten, Ian Campbell, Lisa Devereux, Simone McInerny, Paul A. James and Alison H. Trainer and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Cancer.

In The Last Decade

Michelle W. Wong‐Brown

26 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BCL-2 family isoforms in apoptosis and cancer

2019 508 citations Michelle W. Wong‐Brown, Nikola A. Bowden et al. Cell Death and Disease profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle W. Wong‐Brown Australia	15	734	351	342	325	169	28	1.2k
Christoforos Thomas United States	18	665 0.9×	491 1.4×	254 0.7×	474 1.5×	88 0.5×	30	1.3k
Joan Lewis-Wambi United States	20	631 0.9×	471 1.3×	323 0.9×	424 1.3×	82 0.5×	31	1.3k
Elżbieta Płuciennik Poland	19	604 0.8×	330 0.9×	261 0.8×	255 0.8×	71 0.4×	69	1.1k
Li Lai United States	18	721 1.0×	169 0.5×	212 0.6×	217 0.7×	77 0.5×	43	1.2k
Reba Mustafi United States	24	813 1.1×	163 0.5×	414 1.2×	366 1.1×	224 1.3×	45	1.3k
C Paraskeva United Kingdom	17	1.0k 1.4×	346 1.0×	378 1.1×	606 1.9×	292 1.7×	21	1.9k
Serena Veschi Italy	21	480 0.7×	200 0.6×	266 0.8×	345 1.1×	151 0.9×	51	1.1k
Zhi Ming Shao China	15	806 1.1×	224 0.6×	411 1.2×	776 2.4×	306 1.8×	22	1.4k
Yongxin Zou China	21	1.2k 1.6×	140 0.4×	363 1.1×	269 0.8×	82 0.5×	54	1.5k
Marten Hornsveld Netherlands	13	811 1.1×	107 0.3×	325 1.0×	366 1.1×	85 0.5×	20	1.2k

Countries citing papers authored by Michelle W. Wong‐Brown

Since Specialization

Citations

This map shows the geographic impact of Michelle W. Wong‐Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle W. Wong‐Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle W. Wong‐Brown more than expected).

Fields of papers citing papers by Michelle W. Wong‐Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle W. Wong‐Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle W. Wong‐Brown. The network helps show where Michelle W. Wong‐Brown may publish in the future.

Co-authorship network of co-authors of Michelle W. Wong‐Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle W. Wong‐Brown. A scholar is included among the top collaborators of Michelle W. Wong‐Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle W. Wong‐Brown. Michelle W. Wong‐Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ou, Tong, Hao‐Cheng Yang, Xiaoqiang Zhu, et al.. (2024). ERCC2 mutations alter the genomic distribution pattern of somatic mutations and are independently prognostic in bladder cancer. Cell Genomics. 4(8). 100627–100627. 2 indexed citations

Jaaback, Kenneth, Michelle W. Wong‐Brown, Partha Dutta, et al.. (2024). Fusobacterium nucleatum: An Overview of Evidence, Demi-Decadal Trends, and Its Role in Adverse Pregnancy Outcomes and Various Gynecological Diseases, including Cancers. Cells. 13(8). 717–717. 6 indexed citations

Wong‐Brown, Michelle W., Dongli Liu, Christine Yee, et al.. (2024). Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer. PubMed. 32(4). 200911–200911.

Wong‐Brown, Michelle W., André van der Westhuizen, & Nikola A. Bowden. (2022). Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy. BMC Cancer. 22(1). 100–100. 12 indexed citations

Li, Na, Ella R. Thompson, Simone McInerny, et al.. (2021). Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study. npj Breast Cancer. 7(1). 76–76. 13 indexed citations

Wong‐Brown, Michelle W., et al.. (2019). BCL-2 family isoforms in apoptosis and cancer. Cell Death and Disease. 10(3). 177–177. 508 indexed citations breakdown →

Taylor, Rachael, Roger Smith, Clare E. Collins, et al.. (2018). Methyl-Donor and Cofactor Nutrient Intakes in the First 2–3 Years and Global DNA Methylation at Age 4: A Prospective Cohort Study. Nutrients. 10(3). 273–273. 16 indexed citations

Li, Na, Ella R. Thompson, Simone M. Rowley, et al.. (2016). Reevaluation of RINT1 as a breast cancer predisposition gene. Breast Cancer Research and Treatment. 159(2). 385–392. 12 indexed citations

Mathe, Andrea, Michelle W. Wong‐Brown, Warwick J. Locke, et al.. (2016). DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients. Scientific Reports. 6(1). 33435–33435. 33 indexed citations

10.

Wong‐Brown, Michelle W., Mary McPhillips, Margaret Gleeson, et al.. (2016). When is a mutation not a mutation: the case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in trans. Hereditary Cancer in Clinical Practice. 14(1). 6–6. 4 indexed citations

11.

Thompson, Ella R., Simone M. Rowley, Na Li, et al.. (2016). Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care. Journal of Clinical Oncology. 34(13). 1455–1459. 137 indexed citations

12.

Morten, Brianna C., Michelle W. Wong‐Brown, Rodney J. Scott, & Kelly A. Avery‐Kiejda. (2015). The presence of the intron 3 16 bp duplication polymorphism ofp53(rs17878362) in breast cancer is associated with a low Δ40p53:p53 ratio and better outcome. Carcinogenesis. 37(1). 81–86. 16 indexed citations

13.

Mathe, Andrea, Michelle W. Wong‐Brown, Brianna C. Morten, et al.. (2015). Novel genes associated with lymph node metastasis in triple negative breast cancer. Scientific Reports. 5(1). 15832–15832. 46 indexed citations

14.

Thompson, Ella R., Kylie L. Gorringe, Simone M. Rowley, et al.. (2015). Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls. Breast Cancer Research. 17(1). 111–111. 29 indexed citations

15.

Wong‐Brown, Michelle W., Cliff Meldrum, Jane Carpenter, et al.. (2015). Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer. Breast Cancer Research and Treatment. 150(1). 71–80. 97 indexed citations

16.

Avery‐Kiejda, Kelly A., Brianna C. Morten, Michelle W. Wong‐Brown, Andrea Mathe, & Rodney J. Scott. (2013). The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome. Carcinogenesis. 35(3). 586–596. 67 indexed citations

17.

Chason, Rebecca J., et al.. (2012). Raynaud's Phenomenon of the Nipple. Obstetrics and Gynecology. 119(2 Pt 2). 447–449. 11 indexed citations

18.

Zacharin, Margaret, Anurag Bajpai, C.W. Chow, et al.. (2011). Gastrointestinal polyps in McCune Albright syndrome. Journal of Medical Genetics. 48(7). 458–461. 22 indexed citations

19.

Wong‐Brown, Michelle W., Cecilia Nordfors, David Mossman, et al.. (2011). BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer. Breast Cancer Research and Treatment. 127(3). 853–859. 74 indexed citations

20.

Wong‐Brown, Michelle W. & Ulrich W. Preuss. (2009). Bipolare Störungen und Abhängigkeitserkrankungen. Nervenheilkunde. 28(8). 518–522.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact